[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337088-105":59,"doc-detail-337088-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prevalence-and-molecular-identification-of-protozoan-intestinal-parasitic-infections-in-cancer-patients-and-a-control-group","Prevalence and molecular identification of protozoan intestinal parasitic infections in cancer patients and a control group","","Study prevalence and molecular identification of intestinal protozoan parasitic infections in Iranian cancer patients compared with a healthy control group. A cross-sectional design included 158 individuals with gastrointestinal and non-gastrointestinal cancers and 158 healthy participants. Stool samples were analyzed using direct and concentration microscopy, modified acid-fast staining for coccidian parasites, and DNA extraction followed by PCR and sequencing. Cancer patients showed higher overall protozoan prevalence than controls, with key opportunistic pathogens confirmed by molecular methods.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prevalence-and-molecular-identification-of-protozoan-intestinal-parasitic-infections-in-cancer-patients-and-a-control-group/337088/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prevalence-and-molecular-identification-of-protozoan-intestinal-parasitic-infections-in-cancer-patients-and-a-control-group/337088.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the objective of the study?","Question",{"text":112,"@type":113},"To investigate the prevalence of intestinal protozoan infections in Iranian cancer patients and a control group using microscopic and molecular methods.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were stool samples tested?",{"text":117,"@type":113},"Stool samples were examined by direct and concentration methods, coccidian parasites were detected using modified acid-fast staining, and DNA was analyzed with PCR and sequencing.",{"name":119,"@type":110,"acceptedAnswer":120},"Which protozoa were most common in cancer patients and controls?",{"text":121,"@type":113},"In cancer patients, Blastocystis hominis was most common (22.8%). In the control group, Blastocystis hominis (9.5%) and Giardia lamblia (1.3%) were the most common reported infections.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337088,1790656661,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Bahadorizadeh etal. BMC Infectious Diseases (2024) 24:1355 BMC Infectious Diseases  \n[https://doi.org/10.1186/s12879-024-10235-0](https://doi.org/10.1186/s12879-024-10235-0)  \nRESEARCH Open Access  \nPrevalence and molecular identification of protozoan intestinal parasitic infections in cancer patients and a control group  \nLeyla Bahadorizadeh 1,2, Khadijeh Khanaliha3*, Saeede Ghorbandoust 1, Farah Bokharei-Salim4, Sara Minaeian2, Nastaran Khodakarim5, Marzieh Ghalamkari6 and Borna Salemi7  \nAbstract  \nBackground Parasitic infections, especially opportunistic infections, are important issues for immunocompromised patients, including cancer patients. In this study, the prevalence of intestinal protozoan infections was investigated in Iranian cancer patients and a control group using microscopic and molecular methods.  \nMethods This cross-sectional study was conducted on a group of 158 individuals with gastrointestinal and nongastrointestinal cancers from hospitals affiliated with the Iran University of Medical Sciences, alongside 158 healthy individuals included in the control group. Stool samples were collected and examined using direct and concentration methods. The modified acid-fast staining method was used to detect coccidian parasite infections. DNA was extracted from the patients’ samples, and PCR and sequencing were performed.  \nResults The overall prevalence of protozoan infections was higher in the cancer patients (31 . 6%) than in the control group (12 . 0%), with the difference between the two groups being statistically significant (P = 0 . 0001) . The study identified Blastocystis hominis as the most common protozoan, with a prevalence of 22 . 8%, followed by Giardia lamblia, Entamoeba coli, Dientamoeba fragilis, and Chilomastix mesnili, with rates of 2 . 5%, 1. 3%, 1. 3%, and 0. 6%, respectively, in the cancer patients. Cystoisospora belli and Cryptosporidium sp. were found as opportunistic infections in 2. 5% and 0. 6% of the cancer patients, respectively. Blastocystis hominis, with a prevalence of 9 . 5%, followed by Giardia lamblia at 1. 3%, were the most common parasitic infections in the control group. A statistical difference was found for Cystoisospora belli (P = 0 . 044) and Blastocystis hominis (P = 0 . 0013) between the cancer patients and the control group. Cryptosporidium sp. was confirmed as Cryptosporidium parvum, and Cystoisospora belli was confirmed by PCR sequencing.  \nConclusion Chemotherapy, aside from corticosteroids, increases susceptibility to intestinal Protozoan infections in patients with hematological malignancies, particularly those with lymphoma and leukemia. The results indicateda higher risk of intestinal Protozoan infections, including opportunistic infections, in the cancer patients than in the control group. Cystoisospora belli and Cryptosporidium parvum were found to cause diarrhea in hematological malignancy patients undergoing chemotherapy.  \n*Correspondence: Khadijeh Khanaliha [khanaliha.kh@iums.ac.ir](khanaliha.kh@iums.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will n","cbCainyahGFrHDuh","https://ap.wps.com/l/cbCainyahGFrHDuh","pdf",1387886,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What was the objective of the study?\",\"answer\":\"To investigate the prevalence of intestinal protozoan infections in Iranian cancer patients and a control group using microscopic and molecular methods.\"},{\"question\":\"How were stool samples tested?\",\"answer\":\"Stool samples were examined by direct and concentration methods, coccidian parasites were detected using modified acid-fast staining, and DNA was analyzed with PCR and sequencing.\"},{\"question\":\"Which protozoa were most common in cancer patients and controls?\",\"answer\":\"In cancer patients, Blastocystis hominis was most common (22.8%). In the control group, Blastocystis hominis (9.5%) and Giardia lamblia (1.3%) were the most common reported infections.\"}]","Prevalence and molecular identification of protozoan intestinal parasitic infections in cancer patients and a control group | PDF",1790017652,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3024174de174088ac553199d4023cb6f.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dffa175461fa7fe842e980af5c8fe26f.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/374dd61d30788ddc69685b2f6539aaae.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1a9d852659a406d8aca6b7b27cbeadc.webp",980,1306]